Baton Rouge, LA – SOLA Pharmaceuticals, a Louisiana-based pharmaceutical manufacturer, announced the release of two new over-the-counter medications. Established in 2014, SOLA is a top distributor and manufacturer of legend topical prescription medications and is now making the transition to generic over-the-counter products.
SOLA Pharmaceuticals has a current portfolio of 17 FDA-approved medications, representing a total addressable market of approximately $156 million. Recognizing the need for high-quality over-the-counter alternatives, SOLA launched Hydrocortisone Cream and Clotrimazole Cream in Q4 of 2020 to anchor its OTC portfolio. SOLA plans to add more over-the-counter products in the coming months, including Triple Antibiotic Ointment and Zinc Oxide Ointment, which are expected to launch in Q1 of 2021.
With resources and efficiencies ranging from production to warehousing to shipping, SOLA intends to fill the gap of demand for high-quality over-the-counter medications at a fraction of the cost to consumers in comparison to brand-name products.
About SOLA Pharmaceuticals:
SOLA is a pharmaceutical manufacturer that develops and markets high-quality prescription and over-the-counter medications, with a primary focus on topical medications such as creams, ointments, gels, lotions, and patches. SOLA Pharmaceuticals is headquartered in Baton Rouge, Louisiana, and is FDA registered, cGMP certified, NABP accredited, and DSCSA compliant.
Company Name: SOLA Pharmaceuticals
Contact Person: Steven Faucheaux
Email: Send Email
Country: United States